0

MArS Supplier Spotlight

Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below is an interview with Market Access & Pricing Strategy (MArS), the German-speaking market access experts. Tell us about MArS Market Access… Continue Reading

0

Are you in touch with the latest payer thinking?

In the third of her five-part series on digital transformation in market access, Dr. Patti Peeples, CEO of HealthEconomics.com, sits down with Anja Pownell, Associate Director at PRMA Consulting, to find out how technology is putting dynamic payer thinking at the… Continue Reading

0

Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?

While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have come under increased drug price scrutiny. The American PBM business model, developed in the early 2000s, was designed to identify… Continue Reading

0

Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint

Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the fastest-growing part of healthcare costs, and everyone – from patients, to physicians, policy-makers, and pharmaceutical companies – are grappling with price-setting and drug value assessment.… Continue Reading